2. Average price increase for its products last year was 5%
3. A lot of the growth will come from branded products where they just recently received FDA approval
4. The company is not highly leveraged (they guided for 3-4 times EBITDA by the second half of 2016)
5. No accounting issues
Why are we even lumped together with Valeant? And why are we down twice as much as Valeant is down today?